GlassScriptPhysician profile
Laura Dopson Almquist
NPI 1386058949
$2,065.04
in general payments reported to CMS, 2019-2025
29 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $233 · 2021: $174 · 2022: $402 · 2023: $369 · 2024: $345 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.59 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $428.66 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $235.75 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $142.51 | 2021-2025 | |
| Biogen, INC. | $139.47 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $123.23 | 2019-2023 | Summit Doppler |
| Therapeuticsmd, INC. | $104.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.91 | 2019-2025 | |
| Pfizer INC. | $77.60 | 2022-2024 | |
| Channel Medsystems, INC. | $69.67 | 2022 | |
| Evofem Biosciences, INC. | $69.40 | 2022-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $65.73 | 2024-2025 | Femlyv, Intrarosa |
| Organon LLC | $53.97 | 2024 | |
| Aspira Women'S Health INC | $44.36 | 2023 | Ova1 |
| Smith+Nephew, INC. | $41.36 | 2022-2025 | Pico 7, Pico 14 |
| Avanos Medical | $38.26 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36.98 | 2019-2020 | |
| Daiichi Sankyo INC. | $33.49 | 2019-2020 | |
| Hologic Sales and Service, LLC | $33.27 | 2019-2020 | |
| Agile Therapeutics, INC. | $33.25 | 2021-2022 | |
| Exeltis, USA INC. | $31.75 | 2020-2024 | Slynd |
| Merck Sharp & Dohme LLC | $26.79 | 2021-2024 | Gardasil, Gardasil 9 |
| Convatec INC. | $22.61 | 2023 | |
| Sumitomo Pharma America, INC. | $20.64 | 2023 | Myfembree |
| Avion Pharmaceuticals | $19.49 | 2020 | |
| Shield Therapeutics INC | $19.31 | 2024 | |
| Medtronic, INC. | $18.39 | 2025 | Interstim |
| Abbott Laboratories | $17.96 | 2023 | Freestyle Libre 3 |
| Amag Pharmaceuticals, INC. | $13.96 | 2020 | |
| Scynexis, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Almquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.